We started our activity in 2004 with the first GMP approved facility consisting of two production lines: one for sterile solutions/suspensions (eye drops) and the second for non sterile solutions/suspensions (oral drops, nasal drops/spray, topic solution/spray).

Our state of the art equipment allows us to produce powders, granules or pellets conditioned in capsules, sachets or bottles (dry syrups). To further extend our product range in December 2007 we had started the third facility for injection solutions aseptically produced, with a capacity of 100 million ampoules per year.

Rompharm's philosophy is oriented to product quality, compliance with GMP, along the whole manufacturing and distribution processes. and other in force regulation (EC Directive 2003/94/EC).

Accomplishment of requirements is based upon modern technologies implementation together with a complex system of Quality assurance and validation as a whole. One of the main elements for the maintenance of the quality system is the personnel. Their skills, the creative potential are more valuable than the assets and equipment. That is why each employee of Rompharm Company is an integral part of the quality assurance system.

The range of products released by Rompharm Company is directed on the real and potential capacity of the market, on the level and prospects of demands. Most of our products are generic medicines. The marketing efforts to increase the sales are directed to the medical representatives; it is realized due to company's own network in CIS countries and the relation organized with local distributors.